YM BioSciences (YM.TO) ANNOUNCES NIMOTUZUMAB Results
11/18/2009 11:06:53 AM
More...
|
YM BioSciences (YM.TO) Reports CTY997 Oral Vacular Disrupting Agent Results
11/17/2009 9:56:29 AM
More...
|
YM BioSciences (YM.TO) Reports Financial Results
11/12/2009 11:30:28 AM
More...
|
YM BioSciences (YM.TO) Reports Positive NIMOTUZUMAB Four Year Survial Data
11/3/2009 8:55:39 AM
More...
|
YM BioSciences (YM.TO) Reports Positive Nimotuzumab Four-Year Survival Data Presented at ASTRO 2009
11/2/2009 1:59:19 PM
More...
|
YM BioSciences (YM.TO) Reports Additional Results from NIMOTUZUMAB PHASE III Study
10/30/2009 8:30:41 AM
More...
|
YM BioSciences (YM.TO) Announces $14.05 Million Offer for Cytopia Limited (CYT.AX), an Australian Cancer-Focused Development Company
10/6/2009 6:49:53 AM
More...
|
YM BioSciences (YM.TO) Reports Fiscal Year End 2009 Operational and Financial Results
9/25/2009 8:39:51 AM
More...
|
YM BioSciences (YM.TO) Reports NIMOTUZUMAB Approved for Marketing in Mexico
9/17/2009 9:53:30 AM
More...
|
YM BioSciences (YM.TO) Receives Clearance from US Treasury Department to Expand Clinical Program for NIMOTUZUMAB
8/10/2009 8:00:01 AM
More...
|
|